Sign In
Buy APYX
$4.10
-0.0200 (-0.485%)
At Close: Jul 31, 2026
Apyx Medical Corp (NASDAQ:APYX) Short Interest Update
07:18am, Thursday, 16'th Apr 2020
Apyx Medical Corp (NASDAQ:APYX) was the recipient of a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 527,200 shares, a decrease of 44
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Apyx Medical Corporation ("Apyx" or "the Company") (NASDAQ:APYX)
Goldman Sachs Group Inc. Boosts Stock Position in Apyx Medical Corp (NASDAQ:APYX)
12:02pm, Wednesday, 15'th Apr 2020
Goldman Sachs Group Inc. lifted its position in shares of Apyx Medical Corp (NASDAQ:APYX) by 1,148.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and
Apyx Medical Corp (NASDAQ:APYX) Shares Sold by AQR Capital Management LLC
09:40am, Tuesday, 14'th Apr 2020
AQR Capital Management LLC cut its position in Apyx Medical Corp (NASDAQ:APYX) by 29.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 15,777 shar
APYX LOSS NOTICE: ROSEN, A TOP FIRM, Continues to Investigate Securities Claims Against Apyx Medical Corporation – APYX
07:30pm, Sunday, 12'th Apr 2020
Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Apyx Medical Corporation (NASDAQ: APYX) resulting from allegations
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apyx Medical Corporation - APYX
06:26pm, Sunday, 12'th Apr 2020
Pomerantz LLP is investigating claims on behalf of investors of Apyx Medical Corporation ("Apyx" or the "Company") (NASDAQ: APYX). Such investors are advised to contact Robert S. Willoughby at rswillo
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2020 Financial Results on May 11, 2020
01:25pm, Tuesday, 07'th Apr 2020
Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery m
ValuEngine Downgrades Apyx Medical (NASDAQ:APYX) to Buy
07:20am, Saturday, 04'th Apr 2020
Apyx Medical (NASDAQ:APYX) was downgraded by analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a research report issued on Thursday, ValuEngine reports. APYX has been the
LOS ANGELES, CA / ACCESSWIRE / March 31, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Apyx Medical Co
Apyx Medical Corp (NASDAQ:APYX) Sees Significant Decline in Short Interest
05:04am, Monday, 30'th Mar 2020
Apyx Medical Corp (NASDAQ:APYX) was the recipient of a large drop in short interest in March. As of March 13th, there was short interest totalling 957,200 shares, a drop of 5.2% from the February 27th
Reviewing Titan Medical (NASDAQ:TMDI) and Apyx Medical (NASDAQ:APYX)
05:32am, Saturday, 28'th Mar 2020
Apyx Medical (NASDAQ:APYX) and Titan Medical (NASDAQ:TMDI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their divid
Apyx Medical (NASDAQ:APYX) Stock Price Up 6.8%
06:14am, Thursday, 26'th Mar 2020
Shares of Apyx Medical Corp (NASDAQ:APYX) rose 6.8% during mid-day trading on Tuesday . The company traded as high as $3.58 and last traded at $3.46, approximately 198,110 shares were traded during mi
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Be
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 23.)
Arcutis Biotherapeutics...
Charles Schwab Investment Management Inc. Grows Stake in Apyx Medical Corp (NASDAQ:APYX)
10:14am, Sunday, 22'nd Mar 2020
Charles Schwab Investment Management Inc. grew its position in Apyx Medical Corp (NASDAQ:APYX) by 4.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exch
